Cervarix
Human papillomavirus vaccine / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Cervarix?
Summarize this article for a 10 year old
Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV).
Vaccine description | |
---|---|
Target | human papillomavirus (Types 16 and 18) |
Vaccine type | Protein subunit |
Clinical data | |
Trade names | Cervarix |
AHFS/Drugs.com | Monograph |
MedlinePlus | a610014 |
Routes of administration | Intramuscular injection |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
ChemSpider |
|
NY (what is this?) (verify) |
Cervarix is designed to prevent infection from HPV types 16 and 18, that cause about 70% of cervical cancer cases.[6] These types also cause most HPV-induced genital and head and neck cancers. Additionally, some cross-reactive protection against virus strains 45 and 31 were shown in clinical trials.[7] Cervarix also contains AS04, a proprietary adjuvant that has been found to boost the immune system response for a longer period of time.[8]
Cervarix is manufactured by GlaxoSmithKline. An alternative product, from Merck & Co., is known as Gardasil.[6] Cervarix was voluntarily taken off of the market in the US in 2016 due to low demand.[9]